There were 253 press releases posted in the last 24 hours and 431,464 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image